Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

149

Full text

109

Free full text

Publication Types

Journal Article

146

Review

Research Support, Non-U.S. Gov't

Clinical Trial, Phase II

Multicenter Study

Randomized Controlled Trial

Clinical Trial

Clinical Trial, Phase III

Research Support, N.I.H., Extramural

Clinical Trial, Phase I

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Research Support, U.S. Gov't, Non-P.H.S.

Observational Study

Systematic Review

Case Reports

Meta-Analysis

Clinical Trial Protocol

Letter

Equivalence Trial

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Trastuzumab""[mesh_terms]

149 Results

Searching titles within these results

Novel antibody-drug conjugates: current and future roles in gynecologic oncology.

Joan Tymon-Rosario, Burak Zeybek, Alessandro D Santin

Current opinion in obstetrics & gynecology 2021;33(1):26-33

Free Full Text

Abstract

Circulating levels of MOTS-c in patients with breast cancer treated with metformin.

Elisabet Cuyàs, Sara Verdura, Begoña Martin-Castillo, Javier A Menendez

Aging 2023;15(4):892-897

Free Full Text

Abstract

Reinvention of chemotherapy: drug conjugates and nanoparticles.

Eric Raymond, Tu Nguyen-Ngoc

Current opinion in oncology 2016;27(3):232-42

Full Text

Abstract

Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Jens Huober, Patrik Weder, Karin Ribi, Beat Thürlimann, Jean-Christophe Thery, Qiyu Li, Laurence Vanlemmens, Séverine Guiu, Etienne Brain, Julien Grenier, Florence Dalenc, Christelle Levy, Aude-Marie Savoye, Andreas Müller, Véronique Membrez-Antonioli, Marie-Aline Gérard, Jérôme Lemonnier, Hanne Hawle, Daniel Dietrich, Epie Boven, Hervé Bonnefoi

JAMA oncology 2024;9(10):1381-1389

Free Full Text

Abstract

Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done.

Marzia Mare, Lorenzo Memeo, Cristina Colarossi, Dario Giuffrida

Current oncology (Toronto, Ont.) 2022;29(9):6433-6444

Free Full Text

Abstract

Targeted Therapies in the Treatment of Uterine Serous Carcinoma.

Joan R Tymon-Rosario, Megan Gorman, Alessandro D Santin

Current treatment options in oncology 2022;23(12):1804-1817

Full Text

Abstract

A review of Formulations of Commercially Available Antibodies.

Robert G Strickley, William J Lambert

Journal of pharmaceutical sciences 2021;110(7):2590-2608.e56

Full Text

Abstract

Site-specific antibody drug conjugates for cancer therapy.

Siler Panowski, Sunil Bhakta, Helga Raab, Paul Polakis, Jagath R Junutula

mAbs 2014;6(1):34-45

Free Full Text

Abstract

Application of proteometric approach for identification of functional mutant sites to improve the binding affinity of anticancer biologic trastuzumab with its antigen human epidermal growth factor receptor 2.

Nataraj Balakrishnan, Baskar Gurunathan, Krishna Mohan Surapaneni

Journal of molecular recognition : JMR 2021;33(2):e2818

Full Text

Abstract

Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.

Eiji Oki, Tomoharu Yoshizumi, Sachie Omori, Tomoko Shigechi, Kana Kawaguchi, Hideki Ijichi

Anticancer research 2023;43(5):2371-2377

Full Text

Abstract

A review regarding the article 'The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction-A systematic review'.

Hong Fang, Lei Wang, Liwei Wang, Gang Zhao

Current problems in cardiology 2024;49(5):102526

Full Text

Abstract

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.

Thomas Hatschek, Theodoros Foukakis, Judith Bjöhle, Tobias Lekberg, Hanna Fredholm, Ellinor Elinder, Ana Bosch, Gyula Pekar, Henrik Lindman, Aglaia Schiza, Zakaria Einbeigi, Jamila Adra, Anne Andersson, Lena Carlsson, Ann Charlotte Dreifaldt, Erika Isaksson-Friman, Susanne Agartz, Edward Azavedo, Per Grybäck, Mats Hellström, Hemming Johansson, Claudia Maes, Ioannis Zerdes, Johan Hartman, Yvonne Brandberg, Jonas Bergh

JAMA oncology 2022;7(9):1360-1367

Free Full Text

Abstract

Trastuzumab Deruxtecan-Induced Myotoxicity: First Case Report About Myopathy in Patient With Normal Body Composition and Clinical Insights.

Zhen Qiao, LiuDan Li, Hong Wang, ShuHui Dai, LiTong Ye

Thoracic cancer 2025;16(18):e70168

Full Text

Abstract

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.

Matilda Xinwei Lee, Andrea L A Wong, Samuel Ow, Raghav Sundar, David S P Tan, Ross A Soo, Cheng Ean Chee, Joline S J Lim, Wei Peng Yong, Siew Eng Lim, Boon Cher Goh, Lingzhi Wang, Soo Chin Lee

Targeted oncology 2022;17(2):141-151

Free Full Text

Abstract

The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity.

William H Frishman, Julia B Blanter

Cardiology in review 2020;27(5):256-259

Full Text

Abstract

Results: 1 – 15 / 149

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Trastuzumab""[mesh_terms]

Novel antibody-drug conjugates: current and future roles in gynecologic oncology.

Circulating levels of MOTS-c in patients with breast cancer treated with metformin.

Reinvention of chemotherapy: drug conjugates and nanoparticles.

Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Third- and Late Line Treatments of Metastatic Gastric Cancer: Still More to Be Done.

Targeted Therapies in the Treatment of Uterine Serous Carcinoma.

A review of Formulations of Commercially Available Antibodies.

Site-specific antibody drug conjugates for cancer therapy.

Application of proteometric approach for identification of functional mutant sites to improve the binding affinity of anticancer biologic trastuzumab with its antigen human epidermal growth factor receptor 2.

Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.

A review regarding the article 'The cardioprotective potential of sodium-glucose cotransporter 2-inhibitors in breast cancer therapy-related cardiac dysfunction-A systematic review'.

Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.

Trastuzumab Deruxtecan-Induced Myotoxicity: First Case Report About Myopathy in Patient With Normal Body Composition and Clinical Insights.

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.

The Preventive Role of Angiotensin Converting Enzyme Inhibitors/Angiotensin-II Receptor Blockers and β-Adrenergic Blockers in Anthracycline- and Trastuzumab-Induced Cardiotoxicity.

Results for
""Trastuzumab""[mesh_terms]